BR9103479A - Composto,estereoisomero,composicao farmaceutica e processo para a preparacao de um composto - Google Patents

Composto,estereoisomero,composicao farmaceutica e processo para a preparacao de um composto

Info

Publication number
BR9103479A
BR9103479A BR919103479A BR9103479A BR9103479A BR 9103479 A BR9103479 A BR 9103479A BR 919103479 A BR919103479 A BR 919103479A BR 9103479 A BR9103479 A BR 9103479A BR 9103479 A BR9103479 A BR 9103479A
Authority
BR
Brazil
Prior art keywords
compound
stereoisomer
preparation
pharmaceutical composition
pharmaceutical
Prior art date
Application number
BR919103479A
Other languages
English (en)
Inventor
Michael Edward Flaugh
Michael John Martinelli
John Mehnert Schaus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9103479A publication Critical patent/BR9103479A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR919103479A 1990-08-15 1991-08-14 Composto,estereoisomero,composicao farmaceutica e processo para a preparacao de um composto BR9103479A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56798790A 1990-08-15 1990-08-15
US07/725,177 US5229410A (en) 1990-08-15 1991-07-03 6-substituted-hexahydrobenz[cd]indoles

Publications (1)

Publication Number Publication Date
BR9103479A true BR9103479A (pt) 1992-05-12

Family

ID=27074631

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919103479A BR9103479A (pt) 1990-08-15 1991-08-14 Composto,estereoisomero,composicao farmaceutica e processo para a preparacao de um composto

Country Status (17)

Country Link
US (1) US5229410A (pt)
EP (1) EP0471569A1 (pt)
JP (1) JPH04230664A (pt)
KR (1) KR920004346A (pt)
CN (1) CN1058962A (pt)
AU (1) AU648331B2 (pt)
BR (1) BR9103479A (pt)
CS (1) CS249591A3 (pt)
FI (1) FI913834A (pt)
HU (1) HUT59095A (pt)
IE (1) IE912879A1 (pt)
IL (1) IL99149A0 (pt)
MX (1) MX9100644A (pt)
NO (1) NO176019C (pt)
NZ (1) NZ239334A (pt)
PT (1) PT98639A (pt)
YU (1) YU140391A (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
DK0471515T3 (da) * 1990-08-15 1997-07-21 Lilly Co Eli Ringsubstituerede 2-amino-1,2,3,4-tetrahydronphtalener, 3-aminochromaner og 3-aminothiochromaner
US5641794A (en) * 1991-03-28 1997-06-24 Eli Lilly Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US5292766A (en) * 1992-03-25 1994-03-08 Eli Lilly And Company Method for improving primary memory and/or learning
US5385928A (en) * 1994-05-18 1995-01-31 Eli Lilly And Company Tetrahydrobenz [CD] indazoles, compositions and use
WO1998046353A1 (en) 1997-04-15 1998-10-22 Massachusetts Institute Of Technology Synthesis and application of vapor grafted porous materials
KR20050043568A (ko) * 2003-11-06 2005-05-11 김상현 두족류 연체동물 포획용 분할형 인공패각

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE517732C (de) * 1927-10-27 1931-02-09 Then Rudolf Faerbekufe mit einem drehbaren, trommelartigen Rahmen fuer die auf aus-wechselbaren Faerbestoecken aufgehaengten Waren, insbesondere Struempfe
BE542760A (pt) * 1954-11-12
US3194811A (en) * 1963-09-05 1965-07-13 Merck & Co Inc Aroyl-benzindolyl acids
BE755270A (fr) * 1969-08-27 1971-02-25 Sandoz Sa Nouveaux derives du benzo(cd)indole, leur preparation et medicaments contenant ces derives
FI206974A (pt) * 1973-07-16 1975-01-17 Sandoz Ag
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
FR2522658A1 (fr) * 1982-03-05 1983-09-09 Roussel Uclaf Application a titre de medicaments de derives du trans 4-amino benz (c,d) indol-5-ol ainsi que de leurs sels, compositions les renfermant, nouveaux derives et leur procede de preparation
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
IL74222A (en) * 1984-02-06 1988-07-31 Lilly Co Eli 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them
US4983622A (en) * 1984-02-06 1991-01-08 Eli Lilly And Company 6-substituted-4-dialkylaminotetrahydrobenz(c,d)indoles
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3718892A1 (de) * 1987-06-05 1988-12-22 Bayer Ag Polyhydrobenz(c,d)indol-sulfonamide
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli Xahydrobenz [DC] Induced indoles in position 6, their preparation process and pharmaceutical preparations containing them
US5039820A (en) * 1990-02-26 1991-08-13 Eli Lilly And Company 4-amino-6-iodo-hexahydrobenz(cd)indoles
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles
ZA917355B (en) * 1990-09-17 1992-08-26 Agouron Pharma Antiproliferative substituted naphthalene compounds

Also Published As

Publication number Publication date
KR920004346A (ko) 1992-03-27
NZ239334A (en) 1993-05-26
IE912879A1 (en) 1992-02-26
MX9100644A (es) 1992-04-01
JPH04230664A (ja) 1992-08-19
AU648331B2 (en) 1994-04-21
NO176019C (no) 1995-01-18
EP0471569A1 (en) 1992-02-19
HU912707D0 (en) 1992-01-28
CN1058962A (zh) 1992-02-26
FI913834A (fi) 1992-02-16
PT98639A (pt) 1992-06-30
US5229410A (en) 1993-07-20
FI913834A0 (fi) 1991-08-13
IL99149A0 (en) 1992-07-15
NO913158L (no) 1992-02-17
HUT59095A (en) 1992-04-28
AU8240791A (en) 1992-02-20
YU140391A (sh) 1994-06-10
NO913158D0 (no) 1991-08-13
NO176019B (no) 1994-10-10
CS249591A3 (en) 1992-03-18

Similar Documents

Publication Publication Date Title
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
BR9102305A (pt) Compostos;composicao fungicida,processo para a preparacao de compostos e emprego
BR9609701A (pt) Composição farmacéutica composto e processo para a preparação de compostos
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
BR9000040A (pt) Derivados de 3-aril-pirrolidin-2,4-diona,processo para sua preparacao,composicoes inseticidas,processos para combater insetos e para a preparacao de composicoes e aplicacao
BR9100582A (pt) Derivados 3-arilpirrolidin-2,4-diona policiclicos,processo para sua preparacao,composicoes inseticidas,processo para combater insetos,aplicacao,processo para a preparacao de composicoes
BR9609780A (pt) Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto
PT91731A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas
BR8803901A (pt) Processo para a preparacao de derivados de 1-nitro-2,2-diaminoetileno,composicao praguicida,aplicacao e processo para combater pragas
BR9004852A (pt) Composto,processo para sua preparacao,sua aplicacao e composicao farmaceutica
PT97945A (pt) Processo para a preparacao de composicoes antimalarianas contendo benflumetol ederivados artemeter
BR9103036A (pt) Composto,formulacao farmaceutica e processo para a preparacao do composto
BR9607346A (pt) Composto utilizaç o de um composto composiç o farmacéutica e processo para o tratamento de um mamifero e para e preparaç o de compostos
BR9711340A (pt) Composto composi-Æo farmac-utica e processo para preparar um composto
PT90224A (pt) Processo para a preparacao de composicoes sinergicas contendo imazalilo
BR9100297A (pt) Derivados da pirazolina substituidos,processo para sua preparacao,composicao praguicida,processo para combater pragas e para a preparacao de composicoes
BR9305161A (pt) Composto, composição farmacêutica e processo para a preparação do composto
BR9202446A (pt) Composicao de dentifricio,dentifricio e processo para a preparacao de um dentifricio
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
BR9203383A (pt) Composto,processo para sua preparacao,composicao e processo para proteger plantas,processo para a preparacao de uma composicao e emprego
BR9301107A (pt) Processo para a preparacao de um composto
BR9103479A (pt) Composto,estereoisomero,composicao farmaceutica e processo para a preparacao de um composto
PT97550A (pt) Processo para a preparacao de uma composicao farmaceutica contendo ibuprofeno, e uma prostaglandina
BR8804239A (pt) Processo para a preparacao de um composto,composicao praguicida,aplicacao e processo para combater pragas

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal